A retrospective chart review compared the difference in outcomes between Black patients and White patients with advanced RCC for 3 first-line therapies.
A biologics license application for TLX250-CDx has been submitted to the FDA, as supported by the phase 3 ZIRCON trial ...
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
1Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, Ohio. Search for other works by this author on: 2Department of Biostatistics, Health Informatics and Data ...
Background and objective Ampullary carcinoma (AMPAC) taxonomy is based on morphology ... We assessed histomorphological features and immune cell infiltration by digital pathology according to subtypes ...
Relevance section written by JCO Clinical Cancer Informatics Associate Editor Ziad Bakouny, MD, MSc. The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) prognostic model was ...
Clear cell renal cell carcinoma is the most common form of kidney cancer ... Yujiang Fang Department of Microbiology, Immunology & Pathology, Des Moines University, West Des Moines, IA 50266, USA., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback